The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Half Beta-Prograne 80 mg Prolonged-Release Capsules

80 milligram(s) Prolonged-release capsule

Lexon (UK) LtdPPA1097/018/001

Main Information

Trade NameHalf Beta-Prograne 80 mg Prolonged-Release Capsules
Strength80 milligram(s)
Dosage FormProlonged-release capsule
Licence HolderLexon (UK) Ltd
Licence NumberPPA1097/018/001

Group Information

ATC CodeC07AA Beta blocking agents, non-selective
C07AA05 propranolol


Licence Issued26/09/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back